The oncoproteins c-erb-B2, c-fos and the tumour suppressor protein p53 in human embryos and fetuses

Anatomy and Embryology

Volumn 195, Issue 4, 1997, Pages 345-352

  Miosge, Nicolai ^a   Schneider, Wolfgang ^a   Götz, Werner ^a   Herken, Rainer ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

C erb B2; C fos; Human embryos and fetuses; Immunohistochemistry; p53

Indexed keywords

ONCOPROTEIN; PROTEIN C FOS; PROTEIN P53;

ARTICLE; BONE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONAL TISSUE; FETUS; FETUS (ANATOMY); HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUSCLE; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER; LUNG; MUSCLES; PREGNANCY; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, ERBB-2; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030940741     PISSN: 03402061     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004290050054     Document Type: Article

References (33)

1. Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646
2. Arbuthnot P, Kew M, Fitschen W (1991) c-fos and c-myc expression in human hepatocellular carcinomas. Anticancer Res 11: 921-924
3. Bot FJ, Godschalk JC, Krishnadat KK, Van-der-Knast TH, Bosman FT (1994) Prognostic factors in renal-cell carcinoma: immunohistochemical detection of p53 protein versus clinicopathological parameters. Int J Cancer 57:634-637
4. Bretschneider HJ (1980) Myocardial protection. Thorac Cardiovasc Surg 28:295-302
5. Corbett IP, Henry JA, Angus B, Watchorn CJ, Wilkinson L, Hennessy C, Gullick WJ, Tuzu NL, May FEB, Westly BR, Horne CHW (1990) NCL-CB11, a new monoclonal antibody recognizing the internal domain of the c-erbB-2 oncogene protein effective for use on formalin-fixed, paraffin-embedded tissue. J Pathol 161:15-25
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221
7. Falck VG, Gullick WJ (1989) c-erbB-2 oncogene product staining in gastric adenocarcinoma. An immunohistochemical study. J Pathol 159:107-111
8. Ginsberg D, Mechta F, Yaniv M, Oren M (1991) Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 88:9979-9983
9. Hesketh R (1994) The Oncogene Handbook. Academic Press, London
10. Lane DP (1992) p53, guardian of the genome. Nature 358:15-16
11. Latchman DS (1995) Transcription-factor mutations and disease. N Engl J Med 334:28-33
12. Magrisso IJ, Richmond RE, Carter JH, Pross CB, Gilfillen RA, Carter HW (1993) Immunohistochemical detection of RAS, JUN, FOS and p53 oncoprotein expression in human colorektal adenomas and carcinomas. Lab Invest 69:674-681
13. Merlino G (1994) Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. Cancer Biol 5:13-20
14. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM (1992) Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 101:183-189
15. Moll UM, Riou G, Levine AJ (1992) Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 89:7262-7266
16. Montenarh M (1992) Biochemical propertis of the growth suppressor/oncoprotein p53. Oncogene 7:1673-1680
17. O'Rahilly R, Müller F (1987) Developmental stages in human embryos. Including a revision of Streeter's "Horizon" and a survey of the Carnegie Collection (Carnegie Institution of Washington, Publication 637). Carnegie Institution, Washington
18. Parkes HC, Lillycrop K, Howell A, Craig RK (1990) C-erbB2 mRNA expression in human breast tumors: Comparison with c-erbB2 DNA amplification and correlation with prognosis. Br J Cancer 61:39-45
19. Press F, Cordon-Cardo C, Slamon DJ (1990) Expression of the HER/neu proto-oncogene in normal human adult and foetal tissues. Oncogene 5:953-962
20. Quirke P, Picles A, Tuzi NL, Mohamdee O, Gullick WJ (1989) Pattern of expression of c-erbB-2 oncoprotein in human fetuses. Br J Cancer 60:64-69
21. Sandberg M, Vuorio T, Hirvonen H, Alitalo K, Vuorio E (1988) Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones. Development 102:461-470
22. Scott GK, Dodson JM, Montgomery PA, Johnson RM, Sartup JC, Wong WL, Ullrich A, Shephard HM, Benz CC (1991) p185HER2 signal transduction in breast cancer cells. J Biol Chem 266:14300-14305
23. Slamon DJ, De Kernion JB, Verma IM, Cline MJ (1984) Expression of cellular oncogenes in human malignancies. Science 224:256-262
24. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF (1989) Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712
25. Starzynska T, Bromley M, Ghosh A, Stern PL (1992) Prognostic significance of 53 overexpression in gastric and colorectal carcinoma. Br J Cancer 6:558-562
26. Van de Vijver MJ, Peterse JL, Mooi WJ, Wisman P, Lomans J, Dalesio O, Nusse R (1988) Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. N Engl J Med 319:1239-1245
27. Verrier B, Müller D, Bravo R, Müller R (1986) Wounding a fibroblast monolayer results in the rapid induction of the c-fos proto-oncogene. EMBO J 5:913-917
28. Volm M, Efferth T, Mattern J (1992) Oncoprotein (c-myc, c-erb-B1, c-erb-B2, c-fos) and suppressor gene product (p53) expression in human squamous cell carcinoma of the lung. Anticancer Res 12:11-20
29. Voravud N, Foster CS, Gilbertson JA, Sikora K, Waxman J (1989) Oncogene expression in cholangiocarcinoma and in normal hepatic development. Human Pathol 20:1163-1168
30. Wang Z-Q, Ovitt C, Grigoriadis AE, Möhle-Steinlein U, Rüther U, Wagner EF (1992) Bone and haematopoetic defects in mice lacking c-fos. Nature 36:741-745
31. Weiner DB, Nordberg J, Robinson R, Nowell PC, Gazdar A, Greene MI, Williams WV, Cohen JA, Kern JA (1990) Expression of the neu gene-encoded protein (p185/neu) in human non-small cell carcinomas of the lung. Cancer Res 50:421-425
32. Wu JX, Carpenter PM, Grescens C, Keh R, Niman H, Morris JW, Mercola D (1990) The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene 5:989-1000
33. Zambetti GP, Levine AJ (1993) A comparison of the biological activities of wild-type and mutant p53. FASEB J 7:855-865